CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops an artificial intelligence-driven platform that helps users analyze and extract knowledge from vast amounts of unstructured data related to chemical-biological interactions in patents. It aims to support small and medium-sized life science companies in accelerating drug development and protecting…
Today, new drug development on average costs $2.6 billion and takes 10-14 years.
But, for example, the global health emergencyover the spread of the deadly new coronavirus, is proving to be a crucial real-life test case for industry to aim dramatically reduce thetime it takes to create new vaccines and drugs to combat emerging pandemics.
While AI technologies help to identify thousands ofnew molecules that could be turned into potential medicines, it`s crucial to quickly establish the novelty of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
